Bristol-Myers Squibb (BMY) reported Q1 non-GAAP earnings Thursday of $1.80 per diluted share, compared with a loss of $4.40 a year earlier.
Analysts polled by FactSet expected $1.49.
Revenue for the quarter ended March 31 was $11.2 billion, down from $11.87 billion a year earlier.
Analysts surveyed by FactSet expected $10.7 billion.
The company said it increased its full-year 2025 non-GAAP earnings guidance to $6.70-$7.00 per share from $6.55-$6.85. Analysts surveyed by FactSet expect $6.74.
The company increased it full-year 2025 revenue guidance to about $45.8 billion-$46.8 billion from $45.5 billion. Analysts polled by FactSet expect $45.7 billion.
Bristol-Myers shares were 1.4% higher in premarket trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.